NFKB1 and neoplasm: Of the tumor cells which express both p65 and MenaINV-hi, we found that the majority (~ 65–70%) of tumor cells express p65 in the cytoplasm, indicating that NF-κB signaling is not constitutively activated in these tumor cells under any treatment condition.